These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1387433)

  • 1. Nifedipine versus fosinopril in uninephrectomized diabetic rats.
    Anderson S; Rennke HG; Brenner BM
    Kidney Int; 1992 Apr; 41(4):891-7. PubMed ID: 1387433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short and long term effects of antihypertensive therapy in the diabetic rat.
    Anderson S; Rennke HG; Garcia DL; Brenner BM
    Kidney Int; 1989 Oct; 36(4):526-36. PubMed ID: 2681929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
    Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria.
    Brown SA; Walton CL; Crawford P; Bakris GL
    Kidney Int; 1993 Jun; 43(6):1210-8. PubMed ID: 8391095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.
    Kvam FI; Ofstad J; Iversen BM
    Am J Physiol; 1998 Oct; 275(4):F576-84. PubMed ID: 9755129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR.
    Dworkin LD; Feiner HD; Parker M; Tolbert E
    Kidney Int; 1991 Jun; 39(6):1112-7. PubMed ID: 1895665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats.
    O'Donnell MP; Kasiske BL; Daniels FX; Keane WF
    Diabetes; 1986 Sep; 35(9):1011-5. PubMed ID: 3743905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.
    Dworkin LD; Benstein JA; Parker M; Tolbert E; Feiner HD
    Kidney Int; 1993 Apr; 43(4):808-14. PubMed ID: 8479116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin-converting enzyme inhibitors in experimental diabetes.
    Anderson S
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S51-4. PubMed ID: 16989065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular hemodynamic and structural alterations in experimental diabetes mellitus.
    O'Donnell MP; Kasiske BL; Keane WF
    FASEB J; 1988 May; 2(8):2339-47. PubMed ID: 3282959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal hemodynamic effects of calcium antagonists in rats with reduced renal mass.
    Anderson S
    Hypertension; 1991 Mar; 17(3):288-95. PubMed ID: 1999359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy.
    Fujihara CK; Padilha RM; Zatz R
    Diabetes; 1992 Mar; 41(3):286-93. PubMed ID: 1551488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of diabetic glomerulopathy: hemodynamic considerations.
    Anderson S; Brenner BM
    Diabetes Metab Rev; 1988 Mar; 4(2):163-77. PubMed ID: 3281808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished glomerular capillary hydraulic conductivity precedes morphologic changes in experimental diabetes mellitus in the rat.
    Ellis EN; Wiegmann TB; Savin VJ
    Diabetes; 1992 Sep; 41(9):1106-12. PubMed ID: 1499863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids amplify glomerular injury in rats with renal ablation.
    García DL; Rennke HG; Brenner BM; Anderson S
    Am J Hypertens; 1988 Jan; 1(1):54-7. PubMed ID: 3370134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
    Vora JP; Oyama TT; Thompson MM; Anderson S
    Diabetes; 1997 Jan; 46(1):107-12. PubMed ID: 8971089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular hemodynamics in experimental diabetes mellitus.
    Hostetter TH; Troy JL; Brenner BM
    Kidney Int; 1981 Mar; 19(3):410-5. PubMed ID: 7241881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?
    Castellino P; Shohat J; DeFronzo RA
    Semin Nephrol; 1990 May; 10(3):228-41. PubMed ID: 2190280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of glomerular filtration and plasma flow in experimental diabetic rats.
    Michels LD; Davidman M; Keane WF
    J Lab Clin Med; 1981 Dec; 98(6):869-85. PubMed ID: 7031154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic implications of converting-enzyme inhibitors in renal disease.
    Anderson S; Brenner BM
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):81-7. PubMed ID: 3037894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.